Toyonaka, Japan

Itsuro Sugata

This inventor holds 1 USPTO granted patent. Top assignees: Sumitomo Pharmaceuticals Company Limited, Taisho Pharmaceutical Co., Ltd.. Active years: 1991.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Itsuro Sugata in Vitamin D Derivatives

Introduction

Itsuro Sugata is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of pharmacology, particularly through his innovative work on vitamin D derivatives. His research has led to the development of novel compounds that exhibit excellent pharmacological effects.

Latest Patents

Sugata holds a patent for "Fluorine derivatives of vitamin D.sub.3 and process for producing the." This patent describes novel derivatives of 26,26,26,27,27,27-hexafluorovitamin D.sub.3, which are represented by a specific general formula. The process for preparation involves subjecting a previtamin D.sub.3 derivative to thermal isomerization, resulting in a vitamin D.sub.3 derivative with enhanced properties.

Career Highlights

Throughout his career, Sugata has worked with prominent companies in the pharmaceutical industry. He has been associated with Sumitomo Pharmaceuticals Company Limited and Taisho Pharmaceutical Co., Ltd. His work in these organizations has contributed to advancements in drug development and therapeutic applications.

Collaborations

Sugata has collaborated with esteemed colleagues, including Yoshikazu Saito and Noritaka Hamma. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Itsuro Sugata's contributions to the field of vitamin D derivatives highlight his role as an influential inventor. His patented innovations and collaborations with industry professionals underscore the importance of research in advancing pharmacological science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…